Literature DB >> 25120206

Correlations of (18)F-fluorothymidine uptake with pathological tumour size, Ki-67 and thymidine kinase 1 expressions in primary and metastatic lymph node colorectal cancer foci.

Masatoyo Nakajo1, Masayuki Nakajo, Yoriko Kajiya, Yuko Goto, Megumi Jinguji, Sadao Tanaka, Yoshihiko Fukukura, Atsushi Tani, Michiyo Higashi.   

Abstract

OBJECTIVE: To examine correlations of (18)F-fluorothymidine (FLT) uptake with pathological tumour size and immunohistochemical Ki-67, and thymidine kinase 1 (TK-1) expressions in primary and metastatic node colorectal cancer foci.
METHODS: Thirty primary cancers (PCs) and 37 metastatic nodes (MNs) were included. FLT uptake was assessed by visual scores (non-visible: 0-1 and visible: 2-4), standardized uptake value (SUV), and correlated with size, Ki-67, and TK-1. SUV was measured in visible lesions. FLT heterogeneity was assessed by visual scores (no heterogeneous uptake: 0 and heterogeneous uptake: 1-4).
RESULTS: Forty-two lesions were visible. The visible group showed significantly higher values than the non-visible group in size, Ki-67, and TK-1 (each p < 0.05). Size correlated significantly with visual score (PC; ρ = 0.74 and MN; ρ = 0.63), SUVmax (PC; ρ = 0.49, and MN; ρ = 0.76), and SUVmean (PC; ρ = 0.40 and MN; ρ = 0.76) (each p < 0.05). Visual score correlated significantly with size (ρ = 0.86), Ki-67max (ρ = 0.35), Ki-67mean (ρ = 0.38), TK-1max (ρ = 0.35) and TK-1mean (ρ = 0.25) (each p < 0.05). No significant correlations were found between FLT uptake and Ki-67 or TK-1 in 42 visible lesions (each p > 0.05). Heterogeneous FLT uptake was noted in 73 % (22/30) of PCs.
CONCLUSION: FLT uptake correlated with size. Heterogeneous FLT distribution in colorectal cancers may be one of the causes of weak or lack of FLT uptake/Ki-67 or TK-1 correlation. KEY POINTS: FLT uptake correlated well with tumour size in colorectal cancer. Weak or lack of FLT uptake/Ki-67 and TK-1 correlations were observed. Immunohistochemical Ki-67 and TK-1 expressions are not always correlated with FLT uptake.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25120206     DOI: 10.1007/s00330-014-3379-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  41 in total

1.  Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

Authors:  Jeffrey L Schwartz; Yasuko Tamura; Robert Jordan; John R Grierson; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

Review 2.  Tissue microarray (TMA) applications: implications for molecular medicine.

Authors:  Ronald Simon; Guido Sauter
Journal:  Expert Rev Mol Med       Date:  2003-10-21       Impact factor: 5.600

3.  Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Yoriko Kajiya; Megumi Jinguji; Nobuaki Nishimata; Shunji Shimaoka; Tohru Nihara; Kuniaki Aridome; Sadao Tanaka; Yoshihiko Fukukura; Atushi Tani; Chihaya Koriyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

4.  Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors.

Authors:  J Scott Brockenbrough; Timothee Souquet; Janice K Morihara; Joshua E Stern; Stephen E Hawes; Janet S Rasey; Antoine Leblond; Linda W Wiens; Qinghua Feng; John Grierson; Hubert Vesselle
Journal:  J Nucl Med       Date:  2011-07-15       Impact factor: 10.057

5.  Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.

Authors:  Roland Ullrich; Heiko Backes; Hongfeng Li; Lutz Kracht; Hrvoje Miletic; Kristina Kesper; Bernd Neumaier; Wolf-Dieter Heiss; Klaus Wienhard; Andreas H Jacobs
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

6.  Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.

Authors:  Hui Wang; Jinming Zhang; Jiahe Tian; Baolin Qu; Tianran Li; Yingmao Chen; Jian Liu; Shan Wang
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

7.  In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography.

Authors:  D L Francis; A Freeman; D Visvikis; D C Costa; S K Luthra; M Novelli; I Taylor; P J Ell
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

8.  A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.

Authors:  Jiahe Tian; Xiaofeng Yang; Lijuan Yu; Ping Chen; Jun Xin; Liming Ma; Huiru Feng; Yieyin Tan; Zhoushe Zhao; Wenkai Wu
Journal:  J Nucl Med       Date:  2008-01-16       Impact factor: 10.057

9.  Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy.

Authors:  Yusuf Menda; Laura L Boles Ponto; Kenneth J Dornfeld; Timothy J Tewson; G Leonard Watkins; Michael K Schultz; John J Sunderland; Michael M Graham; John M Buatti
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

10.  The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels.

Authors:  Henryk Barthel; Meg Perumal; John Latigo; Qimin He; Frank Brady; Sajinder K Luthra; Pat M Price; Eric O Aboagye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-04       Impact factor: 9.236

View more
  2 in total

1.  Serum thymidine kinase 1 levels correlate with clinical characteristics of esophageal squamous cell carcinoma.

Authors:  Yong Ji; Xiao-Bo Wu; Jing-Yu Chen; Bin Hu; Qian-Kun Zhu; Xing-Feng Zhu; Min-Feng Zheng
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of 18F-Flurodeoxyglucose Positron Emission Tomography-Computed Tomography in Colorectal Cancer.

Authors:  Yi-Xin Yin; Ming-Zhi Xie; Xin-Qiang Liang; Meng-Ling Ye; Ji-Lin Li; Bang-Li Hu
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.